Advertisement

Prophylaxe und Therapie der akuten septischen Kardiomyopathie

  • U. Müller-Werdan
  • K. Werdan
Chapter

Zusammenfassung

Die „septische akute Myokarditis“ wurde bereits vor 75 Jahren beschrieben (Romberg 1921). Sie kann als spezifische Kardiomyopathie — als Herzbeteiligung im Rahmen der Systemerkrankung „Sepsis“—aufgefaßt werden (Richardson et al. 1996). Für diese Herzschädigung in der Sepsis wurde 1989 von H.-P. Schuster der Begriff „akute septische Kardiomyopathie“ geprägt (Schuster 1989): unterschiedliche Krankheitserreger und Virulenzfaktoren induzieren dabei eine Herzfunktionseinschränkung, charakterisiert einerseits durch ein allen Sepsisformen gemeinsames Schädigungsmuster, andererseits aber auch durch erreger- und toxinspezifische Komponenten.

Literatur

  1. 1.
    Avontuur JAM, Nolthenius RPT, Buijk SLCE, Kanhai KJK, Bruining HA (1998b) Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest 113: 1640–1646CrossRefPubMedGoogle Scholar
  2. 2.
    Avontuur JAM, Stam TC, Jongen-Lavrenic M et al. (1998a) Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF-α and nitrite/nitrate in human septic shock. Intensive Care Med 24: 673–679CrossRefPubMedGoogle Scholar
  3. 3.
    Bakker J, Coffernils M, Kahn RJ, Vincent JL (1996) Blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 171: 221–226CrossRefPubMedGoogle Scholar
  4. 4.
    Bakker J, Coffernils M, Leon M, Gris P, Vincent JL (1991) Blood lactate levels are superior to oxygen derived variables in predicting outcome in septic shock. Chest 99: 956–962CrossRefPubMedGoogle Scholar
  5. 5.
    Bastos PG, Knaus WA, Zimmerman JE et al., The Brazil APACHE III Study Group (1996) The importance of technology for achieving superior outcomes from intensive care. Intensive Care Med 22: 664–669CrossRefPubMedGoogle Scholar
  6. 6.
    Benjamin E, Griffin K, Leibowitz AB et al. (1998) Goal-directed transesophageal echocardiography performed by intensivists to assess ventricular function: Comparison with pulmonary catheterization. J Cardiothor Vasc Anesth 12: 10–15CrossRefGoogle Scholar
  7. 7.
    Bernard GR, Wheeler AP, Russell JA et al., for the Ibuprofen in Sepsis Study Group (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336: 912–918CrossRefPubMedGoogle Scholar
  8. 8.
    Boekstegers P, Weidenhöfer S, Zell R et al. (1994a) Repeated administration of a F (ab)2 fragment of an anti-tumor necrosis factor a monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels. Shock 1: 237–245CrossRefPubMedGoogle Scholar
  9. 9.
    Boekstegers P, Weidenhöfer S, Zell R, Holler E, Kapsner T, Redl H, Schlag, Kaul M, Kempeni J, Werdan K (1994b) Changes in skeletal muscle pO2 after administration of anti-TNFa-antibody in patients with severe sepsis: comparison to interleukin-6 serum levels, APACHE II, and Elebute scores. Shock 1: 246–253Google Scholar
  10. 10.
    Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G (1996) The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 83: 254–261PubMedGoogle Scholar
  11. 11.
    Boldt J, Lenz M, Kumle B, Papsdorf M (1998) Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 24: 147–151CrossRefPubMedGoogle Scholar
  12. 12.
    Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996) Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 24: 835–844CrossRefPubMedGoogle Scholar
  13. 13.
    Briegel J, Kellermann W, Forst H et al., and the Phospholipase A2 Study Group (1994) Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clin Invest 72: 782–787CrossRefGoogle Scholar
  14. 14.
    Briegel J, Schelling G, Haller M, Mraz W, Forst H, Peter K (1996) A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 22: 894–899CrossRefPubMedGoogle Scholar
  15. 15.
    Buhre W, Bendyk K, Weyland A et al. (1998) Assessment of intrathoracic blood volume. Thermo-dye dilution technique vs singlethermodilution technique. Anaesthesist 47: 51–53CrossRefPubMedGoogle Scholar
  16. 16.
    Burns AM, Keogan M, Donaldson M, Brown DL, Park GR (1997) Effects of inotropes on human leucocyte numbers, neutrophil function and lymphocyte subtypes. Br J Anaesth 78: 530–535CrossRefPubMedGoogle Scholar
  17. 17.
    Cheifetz IM, Craig DM, Kern FH et al. (1996) Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. Crit Care Med 24: 1554–1561CrossRefPubMedGoogle Scholar
  18. 18.
    Connors Jr AF, Speroff R, Dawson NV et al., for the SUPPORT Investigators (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276: 889–897 (Letters to the Editor: 1997, 277: 108–114 )Google Scholar
  19. 19.
    Conrad SA, Finkelstein JJ, Madden MR, Burk J, Godwin CW (1990) Cardiovascular dysfunction in multiple organ failure. In: Deitch EA (ed) Multiple organ failure-pathophysiology and basic concepts of therapy. Thieme, New York, pp 172–191Google Scholar
  20. 20.
    Cuthbertson BH, Dellinger P, Dyar OJ et al. (1997) UK guidelines for the use of inhaled nitric oxide therapy in adult ICus. Intensive Care Med 23: 1212–1218CrossRefPubMedGoogle Scholar
  21. 21.
    Daemen-Gubbels CRGH, Groeneveld PHB, Groeneveld ABJ et al. (1995) Methylene blue increases myocardial function in septic shock. Crit Care Med 23: 1363–1370 (Letters to the Editor: 1996; 24: 1093–1094Google Scholar
  22. 22.
    Dhainaut J-F, Dall’Ava J, Mira JP (1993) Coronary hemodynamics and myocardial metabolism in sepsis and septic shock. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York Tokyo, pp 882–892CrossRefGoogle Scholar
  23. 23.
    Didwania A, Miller J, Kassel D, Jackson Jr EV, Chernow B (1997) Effect of intravenous lactated Ringer’s solution infusion on the circulating lactate concentration: Part 3: Results of a prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med 25: 1851–1854Google Scholar
  24. 24.
    Doering L, Lum E, Dracup K, Friedman A (1995) Predictors of between-method differences in cardiac output measurement using thoracic electrical bioimpedance and thermodilution. Crit Care Med 23: 1667–1673CrossRefPubMedGoogle Scholar
  25. 25.
    Erdmann E, Reuschel-Janetschek E (1989) Hämodynamik in der Sepsis and im septischen Schock. Intensivmedizin 26 [Suppl 1]: 16–21Google Scholar
  26. 26.
    Fang K,Krahmer RL,Rypins EB, Law WR (1996) Starling resistor effects on pulmonary artery occlusion pressure in endotoxin shock provide inaccuracies in left ventricular compliance assessments. Crit Care Med 24: 1618–1625CrossRefPubMedGoogle Scholar
  27. 27.
    Gattinoni L, Brazzi L, Pelosi P et al., for the SvO2 collaborative group (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333: 1025–1032CrossRefPubMedGoogle Scholar
  28. 28.
    Ginosar Y, Thijs LG, Sprung CL (1997) Raising the standard of hemodynamic monitoring: Targeting the practice or the practitioner? Crit Care Med 25: 209–211CrossRefPubMedGoogle Scholar
  29. 29.
    Ginz HF, Gottschall V, Schwarzkopf G, Walter K (1998) Exzessive Gewebespeicherung von Kolloiden im retikuloendothelialen System. Anaesthesist 47: 330–334CrossRefPubMedGoogle Scholar
  30. 30.
    Gnaegi A, Feihl F, Perret C (1997) Intensive care physician’s insufficient knowledge of right-heart catheterization at the bedside: Timo to act? Crit Care Med 25: 213–220CrossRefPubMedGoogle Scholar
  31. 31.
    Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107–1116CrossRefPubMedGoogle Scholar
  32. 32.
    Godin PJ, Fleisher LA, Eidsath A et al. (1996) Experimental human endotoxemia increases cardiac regularity: Results from a prospective, randomized, crossover trial. Crit Care Med 24: 1117–1124CrossRefPubMedGoogle Scholar
  33. 33.
    Gorscan III J (1997) Hemodynamic assessment of the critically ill patient using transesophageal echocardiography. In: Pinsky MR (ed) Applied cardiovascular physiology. Springer, Berlin Heidelberg New York Tokyo (Update in intensive care and emergency medicine 28; ed. by Vincent J-L; pp 157–173 )Google Scholar
  34. 34.
    Gorscan J (1995) Quantification of left ventricular function using transesophageal echocardiography. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine 1995: Springer, Berlin Heidelberg New York, pp 575–592CrossRefGoogle Scholar
  35. 35.
    Griffiths RD, Jones C, Palmer TEA (1997) Six-month outcome of critically ill patients given glutamine–supplemented parenteral nutrition. Nutrition 13: 295–302PubMedGoogle Scholar
  36. 36.
    Groeneveld ABJ (1997) Non-invasive Hemodynamic and Metabolic Monitoring. In: Pinsky MR (Ed.) Applied Cardiovascular Physiology (Update in Intensive Care and Emergency Medicine 28; Vincent J-L, Ed); Springer, Berlin Heidelberg New York Tokyo, pp 141–149Google Scholar
  37. 37.
    Grootendorst AF, Bommel EFH van, Hoven B van der et al. (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18: 235 – 240CrossRefPubMedGoogle Scholar
  38. 38.
    Grootendorst AF, Bommel EFH van, Leengoed LAMG van, et al. (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8: 161 – 169CrossRefPubMedGoogle Scholar
  39. 39.
    Hack CE (1996) C 1-inhibitor substitution therapy in septic shock or vascular leak syndrome. Biomed Progr 9: 4 – 7Google Scholar
  40. 40.
    Hack CE, Ogilvie AC, Eisele B et al. (1993) Cl-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19: S 19–5 28Google Scholar
  41. 41.
    Hannemann L, Korell R, Meier-Hellmann A, Reinhart K (1993) Hypertonic solutions in the intensive care unit. Zentralbl Chir 118: 245 – 249PubMedGoogle Scholar
  42. 42.
    Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB, the Ibuprofen Study Group (1991) Effect of ibuprofen in patients with severe sepsis; a randomized, doubleblind, multicenter study. Crit Care Med 19: 1339 – 1347CrossRefGoogle Scholar
  43. 43.
    Hayes MA, Timmins AC,Yau EHS,Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717 – 1722Google Scholar
  44. 44.
    Hayward CS, Kalnins WV, Rogers P et al. (1997) Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol 30: 49 – 56CrossRefPubMedGoogle Scholar
  45. 45.
    Herbertson MJ, Werner HA, Walley KR (1997) Platelet-activating factor antogonism improves ventricular contractility in endotoxemia. Crit Care Med 25: 221 – 226CrossRefPubMedGoogle Scholar
  46. 46.
    Hoffmann JN, Hartl W, Deppisch R et al. (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360 – 1367CrossRefPubMedGoogle Scholar
  47. 47.
    Holzmann A, Hurford WE, Zapol WM (1996) Inhaliertes Stickoxid: State-of-the-Art. Intensivmedizin 33: 89–96Google Scholar
  48. 48.
    Hoogenberg K, Smit AJ, Girbes AR (1998) Effect of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 26: 260 – 265CrossRefPubMedGoogle Scholar
  49. 49.
    Iwai H, Nagaki M, Naito T et al. (1998) Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 26: 873 – 876CrossRefPubMedGoogle Scholar
  50. 50.
    Iwama H, Komatsu T (1998) Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection. Acta Anaesthesiol Scand 42: 590 – 593CrossRefPubMedGoogle Scholar
  51. 51.
    Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdaris JP (1990) Sepsis-related cardiogenic shock. Crit Care Med 18: 1055 – 1060CrossRefPubMedGoogle Scholar
  52. 52.
    Jardin F, Valtier B, Beauchet A, Dubourg O, Bourdarias JP (1994) Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med 20: 550 – 554CrossRefPubMedGoogle Scholar
  53. 53.
    Juste RN, Panikkar K, Soni N (1998) The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 24: 564 – 568CrossRefPubMedGoogle Scholar
  54. 54.
    Kääb S, Pilz G, Appel R, Samtleben W, Gurland HJ, Werdan K (1992) Extrakorporale Therapieverfahren: Möglichkeiten and klinische Relevanz bei Patienten mit septischem Multior-ganversagen. In: Deutsch E, Kleinberger G, Lenz K, Ritz R, Schneeweiß B, Schuster HP, Simbruner G, Slany J (Hrsg) Multiorganversagen. Springer, Wien New York (Intensivmedizinisches Seminar, Bd 4, S 139 – 153 )Google Scholar
  55. 55.
    Karzai W, Reilly JM, Hoffmann WD, Cunnion RE, Danner RL, Banks SM, Parrillo JE,Natanson C (1995) Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis. Am J Physiol 268: H692 – H702Google Scholar
  56. 56.
    Kaw WR (1992) Myocardial depression. In: Gamelli RL, Dreis DJ (eds) Trauma 2000 - Strategies for the New Millenium. Landes, Austin, pp 30 – 35Google Scholar
  57. 57.
    Kodama M, Aoki H, Tani T, Hansawa K (1992) Hemoperfusion using polymyxin B immobilized fiber column for removal of endotoxin. Abstract-Band: Second Conference of the International Endotoxin Society, Wien, 17–20. August 1992; Abstr 38, S 38Google Scholar
  58. 58.
    Kreimeier U, Christ F, Frey L et al. (1997) Small-volume Resuscitation beim hypovolämischen Schock - Konzepte, experimentelle und klinische Ergebnisse - eine Standortbestimmung. Anästhesist 46: 309 – 328CrossRefGoogle Scholar
  59. 59.
    Kreimeier U, Prückner St (1998) Volumentherapie bei Hypovolämie und Schock. Notfall Rettungmed 1: 119 – 129CrossRefGoogle Scholar
  60. 60.
    Kvetan V, Mustafa I, Dobb G, Tan P, Rotondi A (1998) Resuscitation of patients in septic shock - 1st Asia-Pacific Consensus Conference in Critical Care Medicine. Intensive Care World 15: 72 – 83Google Scholar
  61. 61.
    Lefrant J-Y, Bruelle P, Aya AGM et al. (1998) Training is required to improve the reliability of esophageal Doppler to measure cardiac output in critically ill patients. Intensive Care Med 24: 347 – 352CrossRefPubMedGoogle Scholar
  62. 62.
    Levy B, Bollaert PE, Charpentier C et al. (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23: 282 – 287CrossRefPubMedGoogle Scholar
  63. 63.
    Loick HM, Poelaert J, Van Aken H (1997) TEE in Anästhesie und Intensivmedizin - Der diagnostische Stellenwert der transösophagealen Echokardiographie. Anaesthesist 46: 504 – 514CrossRefPubMedGoogle Scholar
  64. 64.
    Löllgen H, Meuret GH (1989) Empfehlungen zur Therapie mit Katecholaminen in der Notfallmedizin. In: Vogel F (Hrsg) Differentialtherapie mit Katecholaminen-Pathophysiologische und klinische Aspekte. Thieme, Stuttgart (Intensivmedizin Notfallmedizin Anästhesiologie, Bd 70, S 11 – 13Google Scholar
  65. 65.
    Manthous CA, Hall JB, Olson D, Singh M, Chatla W, Pohlman A, Kushner R, Schmidt GA, Wood LDH (1995) Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 151: 10 – 14PubMedGoogle Scholar
  66. 66.
    Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephirine or dopamine for the treatment of hyperdynamic sepsic shock? Chest 103: 1826 – 1831CrossRefPubMedGoogle Scholar
  67. 67.
    Martin C, Viviand X, Potie F (1997) Use and misuse of catecholamines: combination in septic shock. In: Vincent J–L (ed) Yearbook of intensive care and emergency medicine 1997. Springer, Berlin Heidelberg New York Tokyo, pp 289 – 301Google Scholar
  68. 68.
    Mattar JA, Shoemaker WC, Diament D et al. (1991) Systolic and diastolic time intervals in the critically ill patient. Crit Care Med 19: 1382 – 1386CrossRefPubMedGoogle Scholar
  69. 69.
    McLuckie A (1996) The COLD system of haemodynamic monitoring. Intensive Care World 13: 24 – 28Google Scholar
  70. 70.
    Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K (1997b) The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 23: 31 – 37CrossRefPubMedGoogle Scholar
  71. 71.
    Meier-Hellmann A, Reinhart K (1997) Cardiovascular support by hemodynamic subset: sepsis. In: Pinsky MR (ed) Applied cardiovascular physiology. Springer, Berlin Heidelberg New York Tokyo (Update in intensive care and emergency medicine 28, ed. by Vincent J-L, pp 230 – 245 )Google Scholar
  72. 72.
    Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Hannemann L (1997a) Epinephrine impairs splanchnic perfusion in septic shock. Intensive Care Med 25: 399 – 404Google Scholar
  73. 73.
    Metrangolo L, Fiorillo M, Friedman G et al. (1995) Early hemodynamic course of septic shock. Crit Care Med 23: 1971 – 1975CrossRefPubMedGoogle Scholar
  74. 74.
    Müller-Werdan U, Kuhn C, Heinroth K et al. (1997b) Die akute septische Kardiomyopathie. Intensivmedizin 34: 333 – 351CrossRefGoogle Scholar
  75. 75.
    Müller-Werdan U, Prondzinsky R, Witthaut R et al. (1997a) Das Herz bei Sepsis and MODS. Wien Klin Wochenschr 109 [Suppl 1]: 3 – 24PubMedGoogle Scholar
  76. 76.
    Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart - molecular mechanisms of septic cardiomyopathy. Landes, Austin, USAGoogle Scholar
  77. 77.
    Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM (1993) Effect of „renal-dose“ dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21: 56 – 61PubMedGoogle Scholar
  78. 78.
    Nicholls T, Shoemaker WC (1998) Recent advances in hemodynamic monitoring and management of the emergency critically ill patient. Curr Opin Crit Care 4: 168 – 174CrossRefGoogle Scholar
  79. 79.
    Packman MI, Rackow EC (1983) Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 11: 165 – 169CrossRefPubMedGoogle Scholar
  80. 80.
    Parker MM, Peruzzi W (1997) Pulmonary artery catheters in sepsis/septic shock. New Horiz 5: 228 – 232PubMedGoogle Scholar
  81. 81.
    Parratt JR, Stoclet J-C, Fleming I (1993) The role of the L-arginine nitric oxide pathway in sepsis and endotoxaemia with special reference to vascular impairment. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York Tokyo, pp 575 – 592CrossRefGoogle Scholar
  82. 82.
    Parrillo JE (1989a) Septic shock in humans: clinical evaluation, pathogenesis, and therapeutic approach. In: Shoemaker WC, Ayres D, Grenvik A, Holbrook PR, Thomposon WL (eds) Textbook of critical care, 2nd edn. Saunders, Philadelphia, pp 1006 – 1024Google Scholar
  83. 83.
    Parrillo JE (1989b) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40: 469 – 485CrossRefPubMedGoogle Scholar
  84. 84.
    Peake SL, Moran JL, Leppard PI (1996) N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Grit Care Med 24: 1302 – 1310CrossRefGoogle Scholar
  85. 85.
    Peter K, Lawin P, Bein T (Hrsg) (1992) Intensivmedizin 1992; Thieme, Stuttgart New York ( Intensivmedizin Notfallmedizin Anästhesiologie, Bd 81 )Google Scholar
  86. 86.
    Pilz G, Stäblein A, Reuschel-Janetschek E, Autenrieth G, Werdan K (1989) The use of scoring systems in patients with cardiogenic and septic shock. In: Schlag G, Redl H (eds) Second Vienna Shock Forum. Liss, New York (Progress in clinical and biological research, vol 308, pp 625 – 631 )Google Scholar
  87. 87.
    Pilz G, McGinn P, Boekstegers P,Kääb S,Weidenhöfer S, Werdan K (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circul Shock 42: 174 – 182Google Scholar
  88. 88.
    Porembka DT (1998) Use of transesophageal and transthoracic echocardiography for monitoring and diagnosis of critical illness. Curr Opin Crit Care 4: 195 – 207CrossRefGoogle Scholar
  89. 89.
    Preiser J-C, Lejeune P, Roman A et al. (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23: 259–264CrossRefPubMedGoogle Scholar
  90. 90.
    Prien T, Wuchkow J (1996) Schwankungsbreite des Herzzeitvolumens bei hyperdynamer Sepsis. Vergleich von Bolus-and kontinuierlicher Thermodilutionsmethode. Intensivmedizin 33: 178–182Google Scholar
  91. 91.
    Prondzinsky R, Müller-Werdan U, Pilz G et al. (1997) Systemische Entzündungsreaktion extrakorporaler Therapieverfahren (II): Der kardiopulmonale Bypass. Wien Klin Wochenschr 109 /110: 346 – 353PubMedGoogle Scholar
  92. 92.
    Pulmonary Artery Catheter Consensus Conference Participants (1997) Pulmonary artery catheter consensus conference: Consensus statement. Crit Care Med 25: 910 – 925CrossRefGoogle Scholar
  93. 93.
    Puybasset L, Rouby JJ (1996) Inhalation of nitric oxide in acute respiratory distress syndrome. Intensivmedizin 33: 140 – 152Google Scholar
  94. 94.
    Quezado ZMN, Natanson C, Ailing DW et al. (1993) A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269: 2221 – 2227CrossRefPubMedGoogle Scholar
  95. 95.
    Rackow EC, Kaufman BS, Falk JL, Astiz ME, Weil MH (1987) Hemodynamic response to fluid repletion in patients with septic shock: evidence for early depression of cardiac performance. Circ Shock 22: 11 – 22PubMedGoogle Scholar
  96. 96.
    Raper R, Sibbald WJ, Driedger AA, Gerow K (1989) Relative myocardial depression in normotensive sepsis. J Crit Care 4: 9 – 18CrossRefGoogle Scholar
  97. 97.
    Raper RF, Sibbald WJ (1988) The effects of coronary artery disease on cardiac function in nonhypotensive sepsis. Chest 94: 507CrossRefPubMedGoogle Scholar
  98. 98.
    Redl G, Germann P, Plattner H, Hammerle A (1993) Right ventricular function in early septic shock states. Intensive Care Med 19: 3 – 7CrossRefPubMedGoogle Scholar
  99. 99.
    Reinelt H, Radermacher P, Fischer G et al. (1997) Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86: 818 – 824CrossRefPubMedGoogle Scholar
  100. 100.
    Reinhart K, Bloos F, Spies C (1995) Vasoactive drug therapy in sepsis. In: Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of sepsis. Springer, Berlin Heidelberg New York Tokyo, pp 207–224 (Update in Intensive Care and Emergency Medicine 19 )Google Scholar
  101. 101.
    Reinhart K, Eyrich K (Hrsg) (1989) Sepsis. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  102. 102.
    Reinhart K, Hannemann L, Kuss B (1990) Optimal oxygen delivery in critically ill patients. Intensiv Care Med 16: S 149-S 155Google Scholar
  103. 103.
    Reinke P (1995) Plasmapherese in der Therapie der Sepsis? Anästhesiol Intensivmed 11 /95: 315 – 316Google Scholar
  104. 104.
    Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K (1993) Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline treated patients with septic shock. Circ Shock 41: 48 – 59PubMedGoogle Scholar
  105. 105.
    Reithmann C, Werdan K (1995) Klinische Ergebnisse der einzelnen therapeutischen Prinzipien: Katecholamine. In: Griebenow R, Gülker H, Dominiak P, Piper HM (Hrsg) Autonomes Nervensystem and Herzinsuffizienz. Thieme, Stuttgart New York, S 214 – 229Google Scholar
  106. 106.
    Richardson P, McKenna W, Bristow M et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841 – 842CrossRefPubMedGoogle Scholar
  107. 107.
    Roberts JS, Bratton SL (1998) Colloid volume expanders: Problems, pitfalls and possibilities. Drugs 44: 621–630Google Scholar
  108. 108.
    Rock P, Silverman H, Plump D, Kecala Z, Smith P, Michael JR, Summer W (1985) Efficacy and safety of naloxone in septic shock. Crit Care Med 14: 28 – 33CrossRefGoogle Scholar
  109. 109.
    Rogers P (1997) Invasive hemodynamic monitoring. In: Pinsky MR (ed) Applied cardiovascular physiology. Springer, Berlin Heidelberg New York Tokyo (Update in intensive care and emergency medicine 28, ed. by Vincent J-L, pp 113 – 128 )Google Scholar
  110. 110.
    Rogiers P, Zhang H, Nagler J, Vincent J-L (1998) Hemofiltration in sepsis and shock: Where do we stand? Intensivmed 35: 228 – 234CrossRefGoogle Scholar
  111. 111.
    Romberg E (1921) Die septische akute Myokarditis. In: Romberg E (Hrsg) Lehrbuch der Krankheiten des Herzens and der Blutgefäße, 3. Aufl. Enke, Stuttgart, S 494Google Scholar
  112. 112.
    Ruokonen E, Takala J, Kari A (1993) Regional blood flow and oxygen transport in patients with the low cardiac syndrome after cardiac surgery. Crit Care Med 21: 1304 – 1311CrossRefPubMedGoogle Scholar
  113. 113.
    Sakka SG, Reinhart K (1996) Volumentherapie im septischem Schock. Intensiv-Notfallbehandl 21: 73 – 79Google Scholar
  114. 114.
    Samtleben W, Bengsch S, Boos K-S, Seidel D (1998) HELP apheresis in the treatment of sepsis. Artificial Organs 22: 43 – 46CrossRefPubMedGoogle Scholar
  115. 115.
    Sasse SA, Chen PA, Mahutte CK (1996) Relationship of changes in cardiac output to changes in heart rate in medical ICU patients. Intensive Care Med 22: 409 – 414CrossRefPubMedGoogle Scholar
  116. 116.
    Schedlowski M, Hosch W, Oberbeck R et al. (1996) Catecholamines modulate human NK cell circulation and function via spleen-independent ß2-adrenergic mechanisms. J Immunol 156: 93 – 99PubMedGoogle Scholar
  117. 117.
    Schierhout G, Robert I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials. Br Med J 316: 961–964Google Scholar
  118. 118.
    Schuster H-P 1989: VI. Schlußfolgerungen. In: Werdan K, Schuster H-P, Schlag G, Spilker G, Neumann R (Hrsg) Sepsis: Toxinwirkung, Herzschädigung, Quantifizierung, supportive Therapie mit Immunglobulinen. Intensivmedizin 26 (Suppl 1 ): 152 – 153Google Scholar
  119. 119.
    Sibbald WJ,Doig GS, Morisaki H (1995) Role of RBC transfusion therapy in sepsis. In: Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of sepsis. Springer, Berlin Heidelberg New York Tokyo, pp 191 – 206Google Scholar
  120. 120.
    Sibbald WJ, Vincent J-L (1995) Roundtable conference on clinical trials for the treatment of sepsis. Chest 107: 522 – 527CrossRefPubMedGoogle Scholar
  121. 121.
    Silverman HJ, Penaranda R, Orens JB, Lee NH (1993) Impaired (3-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21: 31 – 39CrossRefPubMedGoogle Scholar
  122. 122.
    Simon TL, Alverson DC, AuBuchon J et al. (1998) Practice parameter for the use of red blood cell transfusions - developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 122: 130 – 138PubMedGoogle Scholar
  123. 123.
    Singer M (1998) Cardiac output in 1998: Heart 79: 425 – 428Google Scholar
  124. 124.
    Sirtl C, Laubenthal H (1998) Therapie der Hypovolämie, Volumenersatztherapie. In: Madler C, Jauch K-W, Werdan K (Hrsg) Das NAW Buch - praktische Notfallmedizin. Urban & Schwarzenberg, München Wien Baltimore, S 218–226; 2. AuflageGoogle Scholar
  125. 125.
    Smail N, Declére AD, Duranteau J, Vigué, Samii K (1996) Left ventricular function after severe trauma. Intensive Care Med 22: 439 – 442CrossRefPubMedGoogle Scholar
  126. 126.
    Spapa H, Zhang H, Demanet C et al. (1998) Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 113: 1616 – 1624CrossRefGoogle Scholar
  127. 127.
    Spiering W, Es PN van, Leeuw PW de (1998) Comparison of impedance cardiography and dye dilution method for measuring cardiac output. Heart 79: 437 – 441PubMedGoogle Scholar
  128. 128.
    Thijs LG (1995) Fluid therapy in septic shock. In: Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of sepsis. Springer, Berlin Heidelberg New York Tokyo, pp 167–190 (Update in intensive care and emergency medicine 19 )Google Scholar
  129. 129.
    Thomas VL, Nielsen MS (1991) Administration of angiotensin II in refractory septic shock: Crit Care Med 19: 1084 – 1086PubMedGoogle Scholar
  130. 130.
    Thompson BT, Cockroll BA (1994) Renal-dose dopamine: a Siren song? Lancet 344: 7 – 8CrossRefPubMedGoogle Scholar
  131. 131.
    Tighe D, Moss R, Bennen D (1996) Cellular response to inflammation and its antagonism by (32-adrenoceptor agonists. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine 1996. Springer, Berlin Heidelberg New York Tokyo, pp 118 – 134CrossRefGoogle Scholar
  132. 132.
    Traber DL, Meyer J, Traber LD (1993) Cardiac function during hypovolemia. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York Tokyo, pp 194 – 199CrossRefGoogle Scholar
  133. 133.
    Van der Meer NJM, de Vries PMJM (1996) The reliability and applicability of impedance cardiography in the ICU. Intensivmedizin 33: 495 – 500Google Scholar
  134. 134.
    Vincent J-L, Dhainaut J-F, Perret C, Suter P (1998) Is the pulmonary artery catheter misused? A European view. Crit Care Med 26: 1283 – 1287CrossRefPubMedGoogle Scholar
  135. 135.
    Van Deuren M, Frieling JTM, Ven-Jongekrijg J van der, et al. (1998) Plasma patterns of tumor necrosis factor-a ( TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange. Clin Infect Dis 26: 918–923CrossRefGoogle Scholar
  136. 136.
    Vincent J-L, Dhainaut J-F, Perret C, Suter P (1998) Is the pulmonary artery catheter misused? A European view. Crit Care Med 26: 1283 – 1287CrossRefPubMedGoogle Scholar
  137. 137.
    Vincent JL, Bakker J, Marecaux G, Schandene L, Kahn RJ, Dupont E (1992a) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101: 810–815CrossRefPubMedGoogle Scholar
  138. 138.
    Vincent J-L, Dhainaut J-F, Perret C, Suter P (1998) Is the pulmonary artery catheter misused? A European view. Crit Care Med 26: 1283 – 1287CrossRefPubMedGoogle Scholar
  139. 139.
    Vincent JL, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C, Kahn RJ (1992b) Myocardial depression characterizes the fatal course of septic shock. Surgery 111: 660 – 667PubMedGoogle Scholar
  140. 140.
    Vincent JL, Reuse C, Frank N, Contempre B, Kahn RJ (1989) Right ventricular dysfunction in septic shock: assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 33: 34 – 38CrossRefPubMedGoogle Scholar
  141. 141.
    Vincent JL, Thijs LG (eds) (1987) Septic shock - European view. Update in intensive care and emergency medicine 4. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  142. 142.
    Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP (1998) Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 113: 576 – 583CrossRefPubMedGoogle Scholar
  143. 143.
    Weil MH (1998) The assault on the Swan-Ganz catheter - A case history of constrained technology, constrained bedside clinicians, and constrained monetary expenditures. Chest 113: 1379 – 1386CrossRefPubMedGoogle Scholar
  144. 144.
    Weiskopf RB, Viele MK; Feiner J et al. (1998) Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279: 217 – 221CrossRefPubMedGoogle Scholar
  145. 145.
    Werdan K (1995) Towards a more causal treatment of septic cardiomyopathy. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine 1995. Springer, Berlin Heidelberg New York Tokyo, pp 518 – 538CrossRefGoogle Scholar
  146. 146.
    Werdan K, Boekstegers P, Müller U, Pfeifer A, Pilz G, Reithmann C, Hallström S, Koidl B, Schuster HP, Schlag G (1991) Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med Klin 86: 526 – 534Google Scholar
  147. 147.
    Werdan K, Reithmann C (1992) Differentialtherapie mit Katecholaminen. In: Schüttler J, Schwilden H, Lauven PM (Hrsg) Klinische Pharmakologie and rationale Arzeimitteltherapie. Thieme, Stuttgart New York (Intensive Care Med Bd 80, S 133 – 143 )Google Scholar
  148. 148.
    Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU. J Surg Res 63: 11 – 16CrossRefPubMedGoogle Scholar
  149. 149.
    Zell R, Geck P, Werdan K, Boekstegers P (1997) TNF-a and IL-la inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function. Mol Cell Biochem 177: 61–67CrossRefPubMedGoogle Scholar
  150. 150.
    Zeni F, Pain P, Vindimian M, Gay J-P, Gery P, Bertrand M et al. (1996) Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study. Crit Care Med 24: 207–214CrossRefPubMedGoogle Scholar
  151. 151.
    Zwissler B, Briegel J (1998) Right ventricular catheter. Curr Opin Crit Care 4: 177 – 183CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • U. Müller-Werdan
  • K. Werdan

There are no affiliations available

Personalised recommendations